SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-010255
Filing Date
2023-03-31
Accepted
2023-03-31 16:07:10
Documents
95
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2690170
2 ex4-7.htm EX-4.7 32454
3 ex21-1.htm EX-21.1 3820
4 ex31-1.htm EX-31.1 11146
5 ex31-2.htm EX-31.2 11430
6 ex32-1.htm EX-32.1 6552
  Complete submission text file 0001493152-23-010255.txt   11013417

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE vynt-20221231.xsd EX-101.SCH 66670
8 XBRL CALCULATION FILE vynt-20221231_cal.xml EX-101.CAL 119321
9 XBRL DEFINITION FILE vynt-20221231_def.xml EX-101.DEF 321147
10 XBRL LABEL FILE vynt-20221231_lab.xml EX-101.LAB 615029
11 XBRL PRESENTATION FILE vynt-20221231_pre.xml EX-101.PRE 497073
89 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1747553
Mailing Address 2370 STATE ROUTE 70 WEST SUITE 310 CHERRY HILL, NJ 08002
Business Address 2370 STATE ROUTE 70 WEST SUITE 310 CHERRY HILL, NJ 08002 201.528.9200
Vyant Bio, Inc. (Filer) CIK: 0001349929 (see all company filings)

IRS No.: 043462475 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35817 | Film No.: 23787634
SIC: 8071 Services-Medical Laboratories